
Gefurulimab (Klygefa), a once-weekly, self-administered complement C5 inhibitor from Alexion and AstraZeneca, is now approved in the US for adults with AChR-antibody-positive generalized myasthenia gravis.
What happens when athletes stop training for 10 days? Dr. Lazzara discusses a study of resting cerebral blood flow in gray matter and the hippocampus.
In this Medical News Minute, developed exclusively for Neurology Times, Dr. Bobby Lazzara reports on




